van den Belt, Matthias
Gilchrist, Cameron
Booth, Thomas J.
Chooi, Yit-Heng
Medema, Marnix H.
Alanjary, Mohammad
Funding for this research was provided by:
National Research Foundation of Korea (2021R1C1C1012065, 2019R1A6A1A10073437)
Australian Research Council (FT160100233)
European Research Council (948770-DECIPHER)
Nederlandse Organisatie voor Wetenschappelijk Onderzoek (VI.Veni.202.130)
Article History
Received: 10 February 2023
Accepted: 27 April 2023
First Online: 3 May 2023
Declarations
:
: Not applicable.
: Not applicable.
: MHM is a co-founder of Design Pharmaceuticals and a member of the scientific advisory board of Hexagon Bio. All other authors have no conflict of interest.